Privia Health Group, Inc. ( (PRVA) ) has released its Q3 earnings. Here is a breakdown of the information Privia Health Group, Inc. presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Privia Health Group, Inc. is a leading physician enablement company in the United States, operating in the healthcare sector with a focus on building provider networks and offering technology and service solutions to optimize medical practices.
Privia Health has reported a robust financial performance for the third quarter of 2025, with significant increases in net income and adjusted EBITDA compared to the previous year. The company has also raised its full-year guidance, reflecting strong operational and financial metrics.
Key highlights from the earnings report include a 32.5% increase in total revenue, a 147.8% rise in operating income, and a 94.1% increase in net income compared to the third quarter of 2024. The company also reported a 27.1% increase in practice collections and a 61.6% rise in adjusted EBITDA. Additionally, Privia Health announced a strategic acquisition of an ACO business from Evolent Health, which is expected to expand its value-based care footprint.
The company has maintained a strong balance sheet with $441.4 million in cash and no debt, positioning it well for future growth. The acquisition of the ACO business is anticipated to close in the fourth quarter of 2025 and is expected to positively impact adjusted EBITDA in 2026.
Looking ahead, Privia Health’s management remains optimistic about the company’s growth prospects, supported by its strategic initiatives and strong financial position. The raised guidance for 2025 reflects confidence in continued operational excellence and market expansion.